https://clinicaltrials.gov/ct2/show/NCT03951077
https://clinicaltrials.gov/ct2/show/NCT03951077?recrs=abdf&type=Intr&cond=Polycystic+Ovary+Syndrome&lupd_s=05%2F01%2F2019&lupd_d=14
Condition : Polycystic Ovary Syndrome
Interventions : Drug: Elagolix; Drug: Placebo
Sponsor : AbbVie
Not yet recruiting
Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome
NCT03951077
Wed, 15 May 2019 12:00:00 EDT
Last Update Posted: 05/15/19 07:42AM
